University of Arizona CRS

Site Details

LOCATION

1515 N. Campbell Avenue

Tuscon, AZ. 85724

Get Directions

Site Type

CRS

CRS Coordinator

Martha Barron

mbarron@email.arizona.edu

520-626-6887

CRS Leader

Elizabeth Connick

connicke@email.arizona.edu

520-626-6887

Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.